DNLI Latest Press Releases

-- December 10, 2025 --

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 12:14 AM

-- December 9, 2025 --

Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:01 PM

-- December 4, 2025 --

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement Globe Newswire 7:10 AM

Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement Globe Newswire 7:00 AM

-- November 6, 2025 --

Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights Globe Newswire 4:01 PM

Denali Therapeutics Announces Board and Executive Leadership Updates Globe Newswire 4:00 PM

-- October 13, 2025 --

Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) Globe Newswire 4:01 PM

-- August 11, 2025 --

Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software